DiI Liposome@Pemafibrate (K-877) + surface peptide targeting peg2k-PECAM-1 (CD31)

DiI Liposome@Pemafibrate (K-877) + surface peptide targeting peg2k-PECAM-1 (CD31)/DiI Liposome loaded Pemafibrate(K-877) and surface peptide targeting peg2k-PECAM-1 (CD31) is a customized scientific research formulation in the field of cardiovascular targeted drug delivery, which is a PECAM-1 (CD31) targeted pembrolizumab long circulating liposome with DiI fluorescent labeling and a drug loading of 2mg. Currently, it is only in the laboratory research stage and has no clinical products on the market.

msds of DiI Liposome@Pemafibrate (K-877) + surface peptide targeting peg2k-PECAM-1 (CD31)